After five years: the high risk of breast cancer recurrence period

"Large-scale clinical study has confirmed: 68 percent of breast cancer recurrence is distant metastasis, such as bone, lung, liver and brain, and 3 / 4 of the transfer of patients relapse within five years will be killed." A few days ago, from Massachusetts General Hospital, Harvard Medical School Professor of Breast PAULGOSS in breast cancer treatment in the academic, "said the postmenopausal estrogen-positive early breast cancer patients, regardless of their level of progesterone receptor, patients are Adhere to long-term medication to reduce the risk of breast cancer recurrence. " The incidence of breast cancer in a gradual upward trend in recent years in Beijing, Shanghai and other major cities have been ranked female cancer incidence rate of the first. Second Affiliated Hospital of Zhongshan University Professor Su breast cancer every tin that although adjuvant therapy after breast cancer has made great progress, so that the risk of breast cancer recurrence by 30 to 50 percent decline, markedly improved survival rates, but there are still some A recurrence of breast cancer, but the grade still can not be ignored. Large-scale clinical study has confirmed: the main cause of death in patients with breast cancer is a distant breast cancer recurrence. The most common is the bone metastasis, lung, liver and brain. Early breast cancer recurrence in the 2 / 3 above is distant metastasis, direct life-threatening. And distant metastasis and recurrence after five years of survival in patients with only 22 percent, compared with nine percent survive 10 years. Experts point out that five years after breast cancer recurrence is the transfer of high-risk period. Therefore, the treatment of early breast cancer patients after surgery and doctors should also keep in touch. So every tin, 60 percent in China -65% of patients with breast cancer is estrogen-dependent tumors, such patients after surgery for medication to be at least five years, this would reduce the 30 percent risk of cancer recurrence. Finally experts advise, breast cancer patients within two years should be a referral every three months, a year or so investigations tumor targets.